Back

Dapagliflozin effect on functional mitral regurgitation and myocardial remodeling (DEFORM trial)

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Valvular disease and myocardial remodelling: a dangerous liaison Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Zhuoshan Huang

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou (China)

6 More presentations in this session

Presentation thumbnail
Impact of single-valve and multiple-valve heart disease on long-term outcome in patients with chronic heart failure
Doctor K. Hu (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of non-invasive and invasive cardiac damage staging in patients with clinically significant aortic stenosis
Doctor M. Belmonte (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse
Mr A. Cesmat (Chapel Hill, US)
Abstract Slides Video
Presentation thumbnail
Cardiac damage extent in patient with isolated severe aortic stenosis referred to surgical aortic valve replacement: is it reversible after surgery?
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Epidemiology and prognostic relevance of morphofunctional classification of secondary mitral regurgitation
Doctor A. Provencio (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular disease and myocardial remodelling: a dangerous liaison

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources